Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1976-5-25
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Amenorrhea, http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Clinical Research, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods, http://linkedlifedata.com/resource/pubmed/keyword/Diseases, http://linkedlifedata.com/resource/pubmed/keyword/Endometrial Effects, http://linkedlifedata.com/resource/pubmed/keyword/Endometrium, http://linkedlifedata.com/resource/pubmed/keyword/Enzymatic Effects, http://linkedlifedata.com/resource/pubmed/keyword/Enzymes And Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, http://linkedlifedata.com/resource/pubmed/keyword/Genitalia, Female, http://linkedlifedata.com/resource/pubmed/keyword/Iud, http://linkedlifedata.com/resource/pubmed/keyword/Iud, Copper Releasing, http://linkedlifedata.com/resource/pubmed/keyword/Lactation, http://linkedlifedata.com/resource/pubmed/keyword/Maternal Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Menstrual Cycle, http://linkedlifedata.com/resource/pubmed/keyword/Menstruation, http://linkedlifedata.com/resource/pubmed/keyword/Menstruation Disorders, http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Pregnancy, http://linkedlifedata.com/resource/pubmed/keyword/Reproduction, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology, http://linkedlifedata.com/resource/pubmed/keyword/Urogenital System, http://linkedlifedata.com/resource/pubmed/keyword/Uterus
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0019-5189
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
497-8
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: Hyaluronidase activity of human endometrial tissues and uterine fluids was investigated. Endometrial tissue and uterine fluid specimens were obtained from normal human subjects, and different cases of uterine dysfunction induced by steroidal contraceptives, copper IUD, lactational amenorrhea, and in early pregnancy. Hyaluronidase activity was found to increase from Cycle Days 8 to 10 and reach the maximum value during the secretory phase. Hyaluronidase activity was reduced in both endometrial tissue and uterine fluid during lactational amenorrhea and early pregnancy, and was drastically reduced in copper-IUD and steroidal contraceptive users. The low hyaluronidase activity in the early phase of the cycle may be due to rapid growth of endometrial tissue. In the secretory phase, the corresponding activities were found to increase because of high secretory activity and enhanced catabolic processes. In early pregnancy, the low lysosomal enzyme activity may also be explained on the basis of increased endometrium tissue growth. Low hyaluronidase activity of amenorrhic subjects may be due to the absence of ovarian steroids.
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
Hyaluronidase activity of human endometrial tissues & uterine fluids.
pubmed:publicationType
Journal Article